Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Afucosylated VAR2CSA-Specific IgG Reduces Risks of Placental Malaria.

The Journal of infectious diseases·2026
Same author

Fc-fucosylation of Plasmodium falciparum-specific IgG varies with antigen and immunization.

The Journal of infectious diseases·2026
Same author

VAR2CSA-reactive IgG in Brazilian women exposed to <i>Plasmodium falciparum</i> or <i>P. vivax</i> infection during pregnancy.

Infection and immunity·2025
Same author

Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria.

Nature communications·2025
Same author

Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.

The Journal of infectious diseases·2024
Same author

Profiling the Plasmodium falciparum Erythrocyte Membrane Protein 1-Specific Immununoglobulin G Response Among Ghanaian Children With Hemoglobin S and C.

The Journal of infectious diseases·2023

Related Experiment Video

Updated: Jan 27, 2026

Author Spotlight: Enhancing Microinjection Needle Quality by Wet Beveling
06:00

Author Spotlight: Enhancing Microinjection Needle Quality by Wet Beveling

Published on: September 27, 2024

829

Looking for Needles in the Plasmodial Haystack.

Lars Hviid1,2

  • 1Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark lhviid@sund.ku.dk.

Msphere
|March 29, 2019
PubMed
Summary

Developing a Plasmodium falciparum malaria vaccine is challenging due to limited understanding of immunity. Protein microarray technology enables exploring the entire parasite proteome for novel vaccine candidates and exposure markers.

Keywords:
Plasmodium falciparumantibodiesantigensmalaria

More Related Videos

Personalized Needles for Microinjections in the Rodent Brain
10:06

Personalized Needles for Microinjections in the Rodent Brain

Published on: January 24, 2018

11.8K
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

5.9K

Related Experiment Videos

Last Updated: Jan 27, 2026

Author Spotlight: Enhancing Microinjection Needle Quality by Wet Beveling
06:00

Author Spotlight: Enhancing Microinjection Needle Quality by Wet Beveling

Published on: September 27, 2024

829
Personalized Needles for Microinjections in the Rodent Brain
10:06

Personalized Needles for Microinjections in the Rodent Brain

Published on: January 24, 2018

11.8K
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
07:19

Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

Published on: March 24, 2023

5.9K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Parasitology

Background:

  • Plasmodium falciparum malaria is a major global health issue.
  • Current malaria vaccine development faces significant hurdles, including incomplete knowledge of protective immunity mechanisms.
  • The focus on a limited number of parasite proteins has overlooked many potential vaccine targets.

Purpose of the Study:

  • To explore the Plasmodium falciparum proteome for new vaccine candidates.
  • To identify markers of parasite exposure.
  • To advance the understanding of protective immunity against malaria.

Main Methods:

  • Utilized protein microarray technology.
  • Interrogated the entire Plasmodium falciparum parasite proteome.
  • Analyzed parasite antigens as targets of acquired immunity.

Main Results:

  • Identified novel vaccine candidates by screening the parasite proteome.
  • Discovered potential markers for assessing parasite exposure.
  • Expanded the understanding of antigens involved in acquired immunity.

Conclusions:

  • Protein microarray technology offers a powerful approach to discover new malaria vaccine targets.
  • Exploring the full parasite proteome is crucial for overcoming challenges in malaria vaccine development.
  • This research opens new avenues for developing effective malaria vaccines and diagnostic tools.